Risky Business: Evaluating Oocyte Donation
Andrea Gurmankin’s (2001) study on the amount and quality of risk information provided to potential oocyte donors is quite interesting and raises some compelling issues. I share her concern about the valididty of th informed consent provided by donors, but I think the issue is worth further elucidation.
Informed Concent, Health Law, Oocyte Donation
Place of Original Publication
American Journal of Bioethics
1 (4) The American Journal of Bioethics 18 (2001)
Berg, Jessica Wilen, "Risky Business: Evaluating Oocyte Donation" (2001). Faculty Publications. 489.
This document is currently not available here.